Bristol Myers Squibb

bms.com · New York City, United States of America

Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and commercializes prescription medicines for oncology, hematology, immunology, cardiovascular, and other serious diseases. It serves patients worldwide through hospital systems, physicians, and pharmacies, generating revenue from the sale of branded pharmaceutical products and related therapies.

Revenue
$46.0B
Employees
34,000
Founded
1887
Headquarters
New York City, United States of America

What 12 Arbolus experts think of Bristol Myers Squibb

The NPS distribution is heavily weighted towards the positive with 4 responses at 9+ and a majority at 8 or higher. Renewal intent is strong among established, high-spend customers, but a notable proportion (about 36%) report being unsure or not renewing, often in pilot or offboarding stages. Adoption is highest among customers with more than 1 year of implementation and high spend levels. Sentiment is therefore positive, anchored by strong loyalty in mature deployments, though early or pilot users show more mixed intentions.Overall Customer Sentiment: Positive

Who reviewed Bristol Myers Squibb

Total customers 12 12 current · 0 former
Reviews growth +9 in six months
Seniority of respondents
  • C-Suite 67% (8)
  • Director 25% (3)
  • Manager 8% (1)
Revenue Leader Director NPS 8 Undecided
Generalist Generalist C-Suite NPS 4 Not renewing
Revenue Leader C-Suite NPS 9

Employer names and spend open once the report publishes.

Tell us when the Bristol Myers Squibb report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

25 Net Promoter Score, from 12 scored reviews
  • Promoters 5
  • Passives 5
  • Detractors 2

Cumulative NPS by month

+1 over 6 months
  • Dec 7
  • Jan 7
  • Mar 6
  • May 7
  • Jul 8
  • Aug 8

Net Promoter Score across 3 reviews, accumulated up to each month. Category median 25 across 3 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 40%
  • Will renew 4
  • Undecided 4
  • Not renewing 2

Plan to renew, by seniority

  • C-Suite 67% 6 answers
  • Director 0% 3 answers
  • Manager 0% 1 answer
  • 8/10 Average score from customers who will renew
  • 9/10 Average score from undecided customers
  • 4/10 Average score from customers not renewing

Top alternatives

Most weighed by Bristol Myers Squibb customers

For people who use Bristol Myers Squibb

Do you use Bristol Myers Squibb at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 12 customers of Bristol Myers Squibb have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.